Your browser doesn't support javascript.
loading
Fibroblast heterogeneity in pulmonary fibrosis: a new target for therapeutics development?
Tsoyi, Konstantin; Rosas, Ivan O.
Affiliation
  • Tsoyi K; Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Rosas IO; Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA Ivan.Rosas@bcm.edu.
Eur Respir J ; 63(2)2024 Feb.
Article in En | MEDLINE | ID: mdl-38331439
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Fibrosis Limits: Humans Language: En Journal: Eur Respir J / Eur. respir. j / European respiratory journal Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Fibrosis Limits: Humans Language: En Journal: Eur Respir J / Eur. respir. j / European respiratory journal Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom